Quinn Andrew M, Minhajuddin Abu T, Hynan Linda S, Reisch Joan S, Cibas Edmund S
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
Division of Biostatistics, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Cancer Cytopathol. 2017 Jul;125(7):576-580. doi: 10.1002/cncy.21856. Epub 2017 Mar 27.
Although objective measures of cytotechnologist (CT) and cytopathologist (CP) performance exist, challenges remain. Two assumptions deserve examination: CPs' interpretations are correct, and CTs and CPs render interpretations independently of each other. This study presents a CT-CP interpretation comparison and provides insight into these assumptions.
Every gynecologic cytology specimen examined by both a CT and a CP from December 2004 to March 2015 was extracted from the laboratory information system; glandular interpretations were excluded. Excel and SAS were used for CT-CP pair analysis. CT-CP pairs with fewer than 32 specimens (the lowest quartile) were excluded. For the remaining CT-CP pairs, 30 specimens or 10% of the specimens (whichever was higher) were randomly selected for comparison by a weighted κ statistic. κ values greater than 0.6 represented good agreement within CT-CP pairs.
This study evaluated 7116 of 53,241 gynecologic cytology specimens (13.4%) that received CT and CP interpretations. This resulted in 155 pair-specific κ values from 15 CTs and 16 CPs. In aggregate, the κ values had a mean of 0.64, a standard deviation of 0.14, a median of 0.65, and a range of 0.27 to 0.91. Nine CTs exhibited good agreement in the majority of their pair-specific κ values with CPs (high-concordance CTs; 88 pair-specific κ values). This allowed us to identify outlier CPs who did not demonstrate good agreement with high-concordance CTs (16 of 88 pair-specific κ values [18.2%]).
Laboratories can use this κ to determine when CP levels of agreement with CTs depart from those of their peers. Adding this to established metrics can give a more nuanced impression of CP performance. Cancer Cytopathol 2017;125:576-80. © 2017 American Cancer Society.
尽管存在针对细胞技术师(CT)和细胞病理学家(CP)工作表现的客观衡量标准,但挑战依然存在。有两个假设值得审视:细胞病理学家的解读是正确的,以及细胞技术师和细胞病理学家彼此独立地做出解读。本研究对细胞技术师与细胞病理学家的解读进行了比较,并对这些假设进行了深入分析。
从实验室信息系统中提取了2004年12月至2015年3月期间由细胞技术师和细胞病理学家共同检查的每一份妇科细胞学标本;排除了腺性解读。使用Excel和SAS进行细胞技术师 - 细胞病理学家配对分析。排除标本数量少于32份(最低四分位数)的细胞技术师 - 细胞病理学家配对。对于其余的细胞技术师 - 细胞病理学家配对,随机选择30份标本或标本总数的10%(以数量较多者为准),通过加权κ统计量进行比较。κ值大于0.6表示细胞技术师 - 细胞病理学家配对内部具有良好的一致性。
本研究评估了53241份接受细胞技术师和细胞病理学家解读的妇科细胞学标本中的7116份(13.4%)。这产生了来自15名细胞技术师和16名细胞病理学家的155个配对特异性κ值。总体而言,κ值的均值为0.64,标准差为0.14,中位数为0.65,范围为0.27至0.91。9名细胞技术师在其大多数配对特异性κ值上与细胞病理学家表现出良好的一致性(高一致性细胞技术师;88个配对特异性κ值)。这使我们能够识别出与高一致性细胞技术师未表现出良好一致性的异常细胞病理学家(88个配对特异性κ值中的16个[18.2%])。
实验室可以使用此κ值来确定细胞病理学家与细胞技术师的一致性水平何时与其同行不同。将此纳入既定指标可以更细致地反映细胞病理学家的工作表现。《癌症细胞病理学》2017年;125:576 - 80。©2017美国癌症协会。